Αρχή » Αρχείο κατηγοριών » Επιστημονική Ενημέρωση
Συστηματικά και εισπνεόμενα αντιβιοτικά κινολόνης και φθοριοκινολόνης. Κίνδυνος και περιορισμοί στη χρήση.

Συστηματικά και εισπνεόμενα αντιβιοτικά κινολόνης και φθοριοκινολόνης. Κίνδυνος και περιορισμοί στη χρήση.

Συστηματικά και εισπνεόμενα αντιβιοτικά κινολόνης και φθοριοκινολόνης – Κίνδυνος περιοριστικών, μακροχρόνιων και δυνητικά μη αναστρέψιμων παρενεργειών και περιορισμοί στη χρήση. Διαβάστε περισσότερα εδώ 

Unexpected Rosuvastatin-Canagliflozin Adverse Effect Reported

Unexpected Rosuvastatin-Canagliflozin Adverse Effect Reported

Mitchel L. Zoler, PhD August 05, 2020   A 76-year-old woman presented recently to a Toronto-area hospital with acute onset muscle pain, limb weakness, difficulty walking, and rhabdomyolysis associated with a sharp spike in her plasma level of rosuvastatin – a drug she had been on uneventfully for more than 5 years, within days of […]

EFIM Webinar: “Headache: Clinical approach and management of patients with headaches”, 14/9/2020, 20:00-21:00 EET

EFIM Webinar: “Headache: Clinical approach and management of patients with headaches”, 14/9/2020, 20:00-21:00 EET

We are pleased to announce the upcoming webinar organised by the EFIM YI on the topic “Headache: Clinical approach and management of patients with headaches” within Acute Internal and Emergency Medicine, on Monday, 14 September from 20:00 – 21:00 CET. The webinar will be presented by Prof. Ben Lovel  from UK who will be sharing […]

The Clinician Role in Health Care Delivery and Innovation

The Clinician Role in Health Care Delivery and Innovation

The Clinician Role in Health Care Delivery and Innovation

Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns

Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns

Chrysi Koliaki 1, Anastasios Tentolouris 1 , Ioanna Eleftheriadou 1, Andreas Melidonis 2,3, George Dimitriadis 2,4 and Nikolaos Tentolouris 1,* Abstract: The management of patients with diabetes mellitus (DM) in the era of the COVID-19 pandemic can be challenging. Even if they are not infected, they are at risk of dysregulated glycemic control due to […]

European Journal of Internal Medicine: July 2020 (Volume 77) – Clinical practice guidelines adaptation for internists – An EFIM methodology

European Journal of Internal Medicine: July 2020 (Volume 77) – Clinical practice guidelines adaptation for internists – An EFIM methodology

We are pleased to inform you that the Working Group on Critical Appraisal in Internal Medicine has published “Clinical practice guidelines adaptation for internists – An EFIM methodology” in the July issue of EJIM. Read the latest guidelines here .  

Λοιμώξεια και Κάπνισμα

Λοιμώξεια και Κάπνισμα

Δείτε εδώ την παρουσίαση για τη συσχέτιση του καπνίσματος με την πανδημία του Covid-19

EMA suspends Picato as a precaution while review of skin cancer risk continues

EMA suspends Picato as a precaution while review of skin cancer risk continues

On 16 January 2020, EMA recommended that patients stop using Picato (ingenol mebutate), a gel for treating the skin condition actinic keratosis, while it continues its review of the medicine’s safety. EMA’s safety committee (PRAC) is currently reviewing data on skin cancer in patients using Picato. Final results from a study comparing Picato with imiquimod […]

Coronavirus Disease 2019 (COVID-19): Information for Internists

Coronavirus Disease 2019 (COVID-19): Information for Internists

These resources are meant to assist internists seeking to prepare and manage their response. ACP will continue to update this page with resources developed by ACP and other organizations. Read the full article  

Is P2Y12 inhibitor therapy associated with an increased risk of cancer?

Is P2Y12 inhibitor therapy associated with an increased risk of cancer?

Christoph C. Kaufmann, Alexander R. Lyon, Johann Wojta, and Kurt Huber Antiplatelet therapy is a mainstay of cardiovascular therapy and is well established in clinical routine. Recently, the potential risk of solid cancers with P2Y12 inhibitor therapy has been an issue of growing interest. The alleged association primarily originated from the findings of an US […]

Σελίδα 1 of 3123